as a surgeon, the worst moment you can ever have is telling a family that their loved one is dead or severely injured following a medical procedure-sleepless nights, lawsuits are sure to follow. There are plenty of stents, no cardiologist is going to risk his/her career on this crappy (bsx) stent. Even if the late restenosis for bsx is lower, the threat of immediate complications and facing a pissed off and grieving family will deter any physician from using this product. Furthermore, patients (at least insured ones) come to doctors offices with all kinds of info from the internet (at least for elective procedures). You can be sure they are going to demand anything but a bsx stent. Longs better hope this stent debacle doesnt spill over to other bsx produsts. Also, not to piss longs off, but seriously why did you hold on to this stock when it was trading close to 52 wk high and news has been out for a while that there were serious problems with the stent? NEVER TRUST MANAGEMENT OF ANY COMPANY< REMEMBER THEY ARE NOT PRIESTS, JUST PEOPLE WHOSE HIGHEST PRIORITY IN LIFE IS MAKING MONEY>
As a surgeon?
You're no surgeon!
If you were one, you would fully understand the issue and feel great that the new improved models are coming overnight!
The BSX stent is the best thing to ever happen for cardiology and patient care, in the last 50 years!
Take THAT from a real cardiovascular practitioner!
Go back to medical school!
Remember Tylenol.... When a company does the right thing the markets rewards it.
As a JNJ shareholder I'm very concerned that each day that Cordis ships product, certified as "adulterated" by FDA, that a major recall could be more damaging to share price.
It's interesting to note the differce in approach to handling QSR/GMP issues between BSC and JNJ. While JNJ has become adversarial to FDA's finding (April, 04) that Cypher is "adulterated" (defined in the CFR as "not fit for use"), BSC on the other hand has embraced the QSR/GMP's and quickly informed FDA that it had a problem. FDA has acknowledged BSC cooperation and used its discretion to expand the definition of affected lots. Tellingly, you don't see BSC stonewalling FDA on their expanded definition, like Cordis is doing with Cypher.
Contrary to your byline, physicians will be the ones who will lead the way in rewarding BSC for quickly admitting error and fixing the problem.
MD's will kill BSX
by: botechgod (35/M/north brunswick, NJ) 07/17/04 11:10 am
Msg: 29609 of 29621
>>as a surgeon, the worst moment you can ever have is telling a family that their loved one is dead or severely injured following a medical procedure-sleepless nights, lawsuits are sure to follow. There are plenty of stents, no cardiologist is going to risk his/her career on this crappy (bsx) stent.>>
Surgeon my ass, botech....dissecting earthworms in your mom's backyard hardly qualifies. Nice technical jargon in your post: "crappy stent"...wow, good choice of words, dumb ass.
A yahoo message board is hardly the place for technical jargon, its wasted on morons like you.
for all of you comparing JNJ to BSX god help you, theres a lot mor to JNJ than stents or even coronary disease
have fun monday
You must be a JNJ sales rep. If your sales approach is to use scare tactics with Doctors about Taxus they are going to laugh you right out of the office.
The BSX rep will have already been there explaining that the fix has been in for some time and that for safety reasons all prefix stents have been removed from the supply chain. Clear and simple.
The Docs loved Taxus before the recall and with improved safety they will love it still.
This to shall pass.
1. If the fix has been in a long time then BSC was extremely irresponsible if they knew about it this long and did not remove it sooner. 2. I suspect that the doc's will think more about how poorly and irresponsibly this was handled. This problem was identified and known in Europe before the release in the U.S. In fact the sales training included direction on how to avoid the problem when they were getting ready for the U.S. release. Interesting they did not recall it in Europe even though the problem was identified there first.
I guess the fact that that a little hospital in boston (harvard) has already dumped this product hasn't fazed you much
I work in a hospital with just short of 100 cardiologists on staff and about 1100 cardiac operations /yr (cabg/ valves)
Ignorance is bliss
hope you have cash to lose
hahahaaaaaaaaaaaaaaaa, amazingly negative energy coming right back to people like Helene...it might take some time, but what goes around ALWAYS comes around....in the future, when you are a two-faced bitch, guess what--sooner or later you get it back in one form or another.
Still teaching customers to reuse single use items?